Imatinib mesylate discontinuation in patients with chronic...

Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response

Ho-Young Yhim, Na-Ri Lee, Eun-Kee Song, Chang-Yeol Yim, So Yeon Jeon, Seunghwan Shin, Jeong-A Kim, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Year:
2012
Language:
english
Pages:
5
DOI:
10.1016/j.leukres.2012.02.011
File:
PDF, 270 KB
english, 2012
Conversion to is in progress
Conversion to is failed